After a year of publishing The Morning Meeting I’ve spoken with many of you to figure out what comes next: do we go for a premium or sponsorship model?
To keep our work free, sponsorships are the right path forward - but we’re gonna do things differently. We recently launched Bullpen Research, a service designed to help investors understand the companies looking to reach them.
So why research? Why now?
As a rule of thumb, paid-for finance content is gross. From ridiculous target prices to pump and dumps, investors have been burned time and time again by paid promotion - but there are plenty of real companies out there that need marketing help.
As equity research professionals, we’re in a unique position to provide that help while keeping the work valuable to you, the reader. Here’s how:
Reputable companies: Stocks fluctuate, but the risk of bankruptcy or fraud is largely avoidable. No penny stocks, no clinical trial drugs, no “the next 100x”. Credibility is priority #1 - we’ll try to make sure our clients reflect that.
Education focus: No ratings, no target prices. As everyone’s investment criteria is different, our job isn’t to tell you what to buy - it’s to give you the understanding you need to make that decision yourself.
We’ll be launching coverage on our first client tomorrow. I’m stoked, but also intensely aware of the role we need to play for this to work. The same way it’s shaped The Morning Meeting, your feedback is critical to making this great. Don’t be shy.
Importantly, we’re keeping The Morning Meeting exactly as is - with the occasional sponsorship marked in green, like this:
RESEARCH: COMPANY NAME
Thanks for rocking with us all year, we look forward to working for you for many more.
See you Wednesday!
